Pricing Log in Create free account
Saturday 17 October 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Stryker Corporation (SYK) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Stryker Corporation (SYK) trades at a price to free cash flow of 24.0×. Over the past ten years it has ranged from 17.0× (November 2016) to 279× (October 2017); the current reading is higher than 10% of that period. That is in line with the Medical Devices industry median of 23.7× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 31.4× (20.27%)
FY2024 39.3× 9.71%
FY2023 35.9× (21.54%)
FY2022 45.7× 24.12%
FY2021 36.8× 11.65%
FY2020 33.0× (35.23%)
FY2019 50.9× 76.97%
FY2018 28.8× (53.18%)
FY2017 61.5× 95.99%
FY2016 31.4× (36.31%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 25.7× (6.71%)
Mar 2026 27.5× (12.24%)
Dec 2025 31.4× (5.97%)
Sep 2025 33.4× (11.23%)
42 more quarters

Against its own ten years

Low 17.0× High 279×
Ten-year median 39.0×
Current reading's percentile 10

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 13.3×
BSX Boston Scientific Corporation compare 18.0×
MDT Medtronic PLC compare 19.8×
GEHC GE HealthCare Technologies Inc. compare 20.0×
STE STERIS plc compare 23.2×
ABT Abbott Laboratories compare 23.3×
DXCM DexCom, Inc. compare 23.4×
SYK Stryker Corporation 24.0×
EW Edwards Lifesciences Corporation compare 35.6×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on SYK